Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2021-03-05
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut and Oral Microbiome of GDM Patients During Pregnancy
NCT04420507
The Study of Biomarker in Early Diagnosis of GDM by Metabolomics
NCT05733195
The Effect of Early Nutrition Intervention on the Incidence of High-risk Patients With Gestational Diabetes
NCT03550976
A Personal Microbiome-dependent Glucose Response in Healthy Young Volunteers
NCT03686293
Long-term Evaluation of Gestational Endocrine & Metabolic Dynamics
NCT07119177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. The study aims to enroll 50 participants with GDM and 20 participants with non-GDM. They will be provided with medical nutritional intervention and need to collect stool samples before and after intervention, separately. Nutritional professionals provide nutritional suggestions to manage blood glucose via examining food diary . All participants need exam glycated hemoglobin every two weeks and monitor fast blood glucose and 2 hour postprandial blood glucose in a one day. Total times of monitoring blood glucose is at least three times every week. Researchers record the situation of blood glucose both groups. Besides, participants need collect stool sample at 28 weeks (before the intervention) and 32 weeks (after the intervention), respectively. Samples will be sequenced by amplicon to describe the effects of diet intervention on the gut microbiome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GDM group
After participants are enrolled, they would be given medical nutrient treatment. Besides, they need have a follow-up visit every two weeks. Blood glucose, body weight, lifestyle and clinical information are collected. Blood samples and stool samples are collected in 28 and 32 pregnant weeks, respectively.
Diet intervention
Professionals will guide participants to have a standard diet and require them to monitor blood glucose by themselves.
non-GDM group
After participants enrollment, they also would be given medical nutrient treatment. And the other conditions are same as the group of GDM.
Diet intervention
Professionals will guide participants to have a standard diet and require them to monitor blood glucose by themselves.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet intervention
Professionals will guide participants to have a standard diet and require them to monitor blood glucose by themselves.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The range of age is between 18 to 45 years;
* Pregnancy naturally and singleton pregnancy;
* Pregnant women with or without gestational diabetes diagnosed by oral glucose tolerance test at 24 to 28 weeks of pregnancy;
* Those who can skillfully use social software in mobile phones and obey the plan of follow-ups;
* Those who voluntary signing of informing consent.
Exclusion Criteria
* Those who were estimated by endocrinology that their value of blood glucose is controlled by not only diet interventions but also drugs;
* Pregnant women who used antibiotics before 1 month enrollment ;
* Those who combined some metabolic diseases, such as hematological system diseases and nervous system diseases;
* Those who reject signing inform consent.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liangkun Ma
Role: STUDY_CHAIR
Chinese Academic of Medical Science & Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of ob gyn , Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-2842
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.